PyruvateDehydrogenaseE1betasubunit抗体;PyruvateDehydrogenaseE1betasubunit Antibody—艾普蒂

+ +

•  

   

     Western blot analysis of Pyruvate Dehydrogenase E1 beta subunit expression in HeLa cell lysate.    

  
  

The pyruvate dehydrogenase E1 beta subunit (PDHB) is a critical component of the pyruvate dehydrogenase complex (PDC), a mitochondrial multienzyme complex essential for cellular energy metabolism. PDC catalyzes the oxidative decarboxylation of pyruvate to acetyl-CoA, linking glycolysis to the tricarboxylic acid (TCA) cycle. The E1 subunit, a heterotetramer of two alpha (PDHA1) and two beta (PDHB) subunits, facilitates the rate-limiting decarboxylation step. PDHB stabilizes the E1 structure and ensures proper thiamine pyrophosphate (TPP) cofactor binding, enabling enzymatic activity.

Antibodies targeting PDHB are widely used in research to study PDC regulation, mitochondrial dysfunction, and metabolic disorders. Dysregulation of PDC activity, including mutations in PDHB, is associated with rare genetic diseases like pyruvate dehydrogenase deficiency, leading to lactic acidosis and neurological impairments. Additionally, autoantibodies against PDHB are implicated in autoimmune conditions, such as primary biliary cholangitis (PBC), where they contribute to diagnostic criteria.

In experimental settings, PDHB antibodies enable the detection of protein expression via Western blotting, immunohistochemistry, or immunofluorescence, aiding investigations into metabolic adaptations in cancer, diabetes, and neurodegenerative diseases. They also help elucidate post-translational modifications (e.g., phosphorylation) that regulate PDC activity. As metabolic reprogramming gains attention in disease mechanisms, PDHB antibodies remain vital tools for exploring mitochondrial bioenergetics and therapeutic targets.